Cargando…

APOL1, Sickle Cell Trait, and CKD in the Jackson Heart Study

RATIONALE & OBJECTIVE: Apolipoprotein L1 (APOL1) high-risk variants are associated with an increased risk for chronic kidney disease (CKD) among African Americans. Less is known regarding the risk for the development of CKD and kidney failure (end-stage kidney disease [ESKD]) among African Ameri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Bessie A., Wilson, James G., Reiner, Alex, Kestenbaum, Bryan, Franceschini, Nora, Bansal, Nisha, Correa, Adolfo, Himmelfarb, Jonathan, Katz, Ronit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664705/ https://www.ncbi.nlm.nih.gov/pubmed/34939005 http://dx.doi.org/10.1016/j.xkme.2021.05.004

Ejemplares similares

Tubular Secretion and Estimated GFR Decline in the Jackson Heart Study
por: Granda, Michael L., et al.
Publicado: (2022)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death
por: Arora, Nayan, et al.
Publicado: (2020)

Sickle Cell Trait, European Ancestry, and Longitudinal Tracking of HbA(1c) Among African Americans: The Jackson Heart Study
por: Echouffo-Tcheugui, Justin B., et al.
Publicado: (2019)

APOL1, Sickle Cell Trait, and Glutathione S-Transferase 1—More Complicated Than It Seems
por: Kruzel-Davila, Etty, et al.
Publicado: (2022)

Mortality Burden and Life-Years Lost Across the Age Spectrum for Adults Living with CKD
por: Kula, Alexander J., et al.
Publicado: (2023)

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
por: Bansal, Nisha, et al.
Publicado: (2019)

High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study
por: Mwasongwe, Stanford E., et al.
Publicado: (2018)

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients
por: Robinson-Cohen, Cassianne, et al.
Publicado: (2016)

JC Virus and APOL1 Risk Alleles in Black South Africans With Hypertension-Attributed CKD
por: Nqebelele, Nolubabalo U., et al.
Publicado: (2019)

APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study
por: Stanifer, John W., et al.
Publicado: (2017)

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury
por: Andrews, Michael, et al.
Publicado: (2022)

Taqman Assay for Genotyping CKD-Associated APOL1 SNP rs60910145: A Cautionary Note
por: David, Victor A., et al.
Publicado: (2018)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Obesity and overall mortality: findings from the Jackson Heart Study
por: Min, Yuan-I, et al.
Publicado: (2021)

APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study
por: Masimango, Mannix Imani, et al.
Publicado: (2021)

MYH9 and APOL1 Gene Polymorphisms and the Risk of CKD in Patients with Lupus Nephritis from an Admixture Population
por: Colares, Vinícius Sardão, et al.
Publicado: (2014)

Sleep Characteristics and Measures of Glucose Metabolism in Blacks: The Jackson Heart Study
por: Yano, Yuichiro, et al.
Publicado: (2020)

Association of APOL1 Genotypes With Measures of Microvascular and Endothelial Function, and Blood Pressure in MESA
por: Chen, Teresa K., et al.
Publicado: (2020)

Effect of APOL1 disease risk variants on APOL1 gene product
por: Haque, Shabirul, et al.
Publicado: (2017)

Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease
por: Raffield, Laura M., et al.
Publicado: (2018)

Digital Connectedness in the Jackson Heart Study: Cross-sectional Study
por: Anugu, Pramod, et al.
Publicado: (2022)

Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Chen, Teresa K., et al.
Publicado: (2017)

Low use of routine medical care among African Americans with high CKD risk: the Jackson Heart Study
por: Diamantidis, Clarissa J., et al.
Publicado: (2019)

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease
por: Bosworth, Cortney, et al.
Publicado: (2012)

Milt Jackson
Publicado: (1989)

Hughlings Jackson
Publicado: (1915)

Daniel Jackson
Publicado: (1911)

Ian T. Jackson
por: Bhattacharya, Surajit
Publicado: (2020)

Samuel Jackson
por: Middleton, William S.
Publicado: (1935)

Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study
por: Echouffo-Tcheugui, Justin B., et al.
Publicado: (2022)

Marsyas und apoll : fur flöte ünd klavier /
por: Muench, Gerhart, 1907-1988
Publicado: (1991)

Cross-sectional and longitudinal analyses of variations of anthropometric measures of obesity with age in the Jackson Heart Study
por: Gao, Yan, et al.
Publicado: (2023)

Genetic underpinnings of regional adiposity distribution in African Americans: Assessments from the Jackson Heart Study
por: Anwar, Mohammad Y., et al.
Publicado: (2021)

Relationship between social support and incident hypertension in the Jackson Heart Study: a cohort study
por: Harding, Barbara N, et al.
Publicado: (2022)

Transcription and translation of APOL1 variants
por: Ejaz, Samina
Publicado: (2017)

The metabolic effects of APOL1 in humans
por: Adeva-Andany, María M., et al.
Publicado: (2023)

Raquel Jackson : un gran corazón; la vida de Raquel y Andrés Jackson
por: Stone, Irving 1903-
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_pd8hrsi25db1hnnb45r57rkbqg